Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infection (C. difficile-associated diarrhoea) in Ireland
**Background:** Clostridium difficile is associated with 20–30% of cases of antibiotic-associated diarrhoea. The incidence of C. difficile infection (CDI) is higher in Ireland than in other countries in Europe, and it is associated with considerable morbidity. Previously recommended standard therape...
Saved in:
Main Authors: | Anke van Engen, Montserrat Casamayor, Fidelma Loftus, Martin Coen, Andy Garnham, Maureen Watt, Larry Lacey |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2015-05-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9903 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
<i>Clostridium difficile</i>-associated disease
by: V. T. Ivashkin, et al.
Published: (2015-12-01) -
Mycophenolate Mofetil and Clostridium difficile-associated Colitis
by: A. I. Dolgushina, et al.
Published: (2021-12-01) -
Clinical characteristics and risk factors of Clostridioides difficile infection in children with diarrhoea
by: Ning Wang, et al.
Published: (2025-02-01) -
The effect of Clostridium difficile infection on the course of liver cirrhosis
by: A. A. Driga, et al.
Published: (2018-08-01) -
Clostridium difficile: An Important Opportunistic Pathogen in Healthcare-Associated Infections
by: Soohyoun Ahn, et al.
Published: (2018-01-01)